Bizarre Patents
A forehead support apparatus for resting a standing users forehead against a wall above a bathroom commode or urinal or beneath a showerhead.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7368443 | 2,6-disubstituted piperidines and piperazine compounds The present invention is directed to 2,6-disubstituted piperidine and piperazine analogs having the following general formula: which are used to treat diseases of the central nervous system, drug abuse, and withdrawal there... | 05/06/2008 |
| 7271161 | Platinum complexes as antitumor agents in combination with biochemical modulation The present invention concerns the use of methods and compositions for the treatment of cancer and other hyperproliferative diseases. In certain embodiments, methods are described for the treatment of cancer and/or hyperproliferative diseases by administration of co... | 09/18/2007 |
| 7229803 | Reaction of (di)amines in the presence of a lysine oxidase and of a reducing agent The invention relates to methods for reacting (di)amines as substrates in the presence of a lysine oxidase arid a reducing agent, resulting in alcohols, diols or cyclic secondary amines. In a particular embodiment, the invention is directed to methods of preparing c... | 06/12/2007 |
| 7214714 | 20-hydroxyeicosatetraenoic acid production inhibitors A hydroxyformamidine compound represented by the following formula or a pharmaceutically acceptable salt thereof [wherein R1 represents a substituted morpholino group, a substituted piperidino group, a... | 05/08/2007 |
| 7122677 | NK1 antagonists A NK1 antagonist having the formula (I), wherein Ar1 and Ar2 are optionally substituted phenyl or heteroaryl, X1 is an ether, thio or imino linkage, R4 and R5... | 10/17/2006 |
| 7098203 | Homopiperidine derivatives as NK-1 antagonists The present disclosure relates to chemical compounds and their use in human therapy. In a specific embodiment, compounds of Formula (I) or an isomer, a pharmaceutically acceptable salt or solvate thereof or a pharmaceutically acceptable formulation comprising said c... | 08/29/2006 |
| 7078537 | Phenylalkyl diamine and amide analogs The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the s... | 07/18/2006 |
| 6967196 | Sulfonamide compounds and uses thereof In accordance with the present invention, there is provided a novel class of sulfonamide compounds. Compounds of the invention contain a core sulfonamide group. Variable moieties connected to the sulfur atom and nitrogen atom of the sulfonamide group include substit... | 11/22/2005 |
| 6964976 | Amino alcohol derivatives Compounds of formula (I) which exhibit excellent immune suppression activity, pharmacologically acceptable salts thereof, esters thereof or other derivatives: wherein R1 and R2 are a hydrogen atom... | 11/15/2005 |
| 6960574 | Antagonists of RF-amide neuropeptides Disclosed are compounds having the formula: where R1=H, C1-C6 alkyl, cycloalkyl, R2... | 11/01/2005 |
| 6943177 | Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies Cis-2,6-disubstituted piperdine analogs, or lobeline analogs, having the general formula: are used to treat diseases of the central nervous system, drug abuse and withdrawal therefrom as well as to treating eating diso... | 09/13/2005 |
| 6908914 | Antipsychotic cyclic N-aralkylamines The invention relates to benzene derivatives, to pharmaceutical compositions containing them, to processes for preparing them, and to the method of use thereof in the treatment of psychotic disorders. ... | 06/21/2005 |
| 6890920 | Quaternary ammonium compounds Novel quaternary ammonium compounds of the formula and any stereoisomers thereof, wherein R1, R2 and R3 independently represent C1-C6 alkyl, optionally substituted... | 05/10/2005 |
| 6825217 | Carbinols for the treatment of neuropathic dysfunction Compositions and methods are provided for treating neuropathic pain or neuropathic dysfunction that include the administration of an effective amount of a defined carbinol or a pharmaceutically acceptable salt or prodrug thereof. ... | 11/30/2004 |
| 6812244 | Naphthyl compounds, intermediates, compositions, and methods of use The instant invention provides novel substituted naphthyl compounds, intermediates, compositions, pharmaceutical formulations, and methods of use. ... | 11/02/2004 |
| 6797707 | Antagonists of RF-amide neuropeptides Disclosed are compounds having the formula: where R1=H, C1-C6 alkyl, cycloalkyl, R2=H, C1-C6 alkyl, cycloalkyl | 09/28/2004 |
| 6770595 | Cyclic imines as pesticides The invention relates to novel cyclic imines of the formula (I) in which Ar1 and Ar2 each represent substituted phenyl and n represents 1, 2 or 3, to a plurality of processes fo... | 08/03/2004 |
| 6599920 | Naphthalene compounds, intermediates, formulations, and methods This invention relates to the field of pharmaceutical and organic chemistry and provides naphthalene compounds, intermediates, formulations, and methods.... | 07/29/2003 |
| 6555542 | Sulfonamide lactam inhibitors of FXa and method Sulfonamide lactams of the following formula ##STR1## wherein X, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R7 and R8 are as described herein, ... | 04/29/2003 |
| 6534499 | N-substituted-N'-substituted urea derivatives and the use thereof as TNF- production inhibitory agents N-Substituted-N'-substituted urea derivatives represented by the following formula, analogs thereof or pharmaceutically acceptable salts thereof are herein provided. These compounds show a TNF- production inhibitory activity. ##STR1##... | 03/18/2003 |
| 6509356 | 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity A class of substituted benzylnaphthylene compounds of the structure ##STR1## where R1 and R2 are independently hydrogen, alkyl of one to six carbon atoms, acyl of two to six carbon atoms, or phenacyl; X is --(CH2)1-6 | 01/21/2003 |
| 6495543 | Polycyclic azaindole compounds The invention relates to compounds of formula (I): ##STR1## wherein: G1 represents an alkylene chain as defined in the description, A represents ##STR2## R2 and R3 represent hydrogen, alkyl, alkoxy or hydroxy or together f... | 12/17/2002 |
| 6495568 | Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors Compounds of formula (I): ##STR1## or pharmaceutically or veterinarily acceptable salts thereof, or pharmaceutically or veterinarily acceptable solvates of either entity, wherein the broken line represents an optional bond; A is C or CH; B is CH... | 12/17/2002 |
| 6451824 | Sulfonylaminocarboxylic acids Compounds of formula (I) ##STR1## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved.... | 09/17/2002 |
| 6437137 | Naphthyl compounds, intermediates, processes, compositions, and methods The invention is a process for preparing a compound of formula Ia ##STR1## comprising reducing the compound of formula IIId ##STR2## wherein R3 is 1-piperidinyl, 1-pyrrolidinyl, dimethylamino, diethylamino or 1-hexamethyleneimino, R1a | 08/20/2002 |
| 6432982 | Benzothiophenes, and formulations and methods using same The invention provides novel benzothiophenes of the formula: ##STR1## wherein R1 is --H, --OH, --O(C1 -C4 alkyl), --O--CO(C1 -C6 alkyl), --OSO2 (C4 -C6 alkyl, or --OCOAr wh... | 08/13/2002 |
| 6410564 | Naphthyl compounds, intermediates, processes, compositions, and methods The present invention provides a compound of formula I ##STR1## wherein R1 is --H, --OH, --O(C1 -C4 alkyl) , --OCOC6 H5, --OCO(C1 -C6 alkyl), or --OSO2 (C4 -C | 06/25/2002 |
| 6362373 | Chiral amino alcohols and process for preparation of same The disclosed invention comprises a compound having the formula: ##STR1## in which R1 and R2 independently represent a hydrogen or an alkyl group of 4 carbon atoms or greater. Further disclosed is a process for the preparation of the... | 03/26/2002 |
| 6362177 | Cyclic amine derivatives and their use as drugs ##STR1## A compound represented by the general formula (I), a pharmaceutically acceptable acid addition salt thereof or a pharmaceutically acceptable C1 -C6 alkyl addition salt thereof, and their medical applications. These compounds... | 03/26/2002 |
| 6352981 | Substituted AZA- and diazacycloheptane and -cyclooctane Aza- and diazacyclohexane and -cyclooctane compounds of the following formula: Ar1 --A--B--Ar2 (I) where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopamine D3 | 03/05/2002 |
| 6350884 | Acrylic and propionic acid compounds, intermediates, processes, compositions, and method This invention is directed to a class of acrylic and propionic acid compounds and their use in the treatment of post-menopausal symptoms and restenosis. In other embodiments, the invention is directed to intermediates and to processes for the preparation ... | 02/26/2002 |
| 6323223 | Cyclic amine derivatives- CCR-3 receptor antagonists This invention relates to certain cyclic amine derivatives of Formula (I) ##STR1## that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.... | 11/27/2001 |
| 6281206 | Amidino protease inhibitors Amidino and benzamidino compounds, including compounds of the formula: ##STR1## wherein R1 -R4, R6 -R9, Y, Z, n and m are set forth in the specification, as well as hydrates, solvates or pharmaceutically accepta... | 08/28/2001 |
| 6242605 | Aryloxy-alkyl-dialkylamines The present invention provides compounds useful in the synthesis of biologically active compounds, and processes for their production, the compounds having the formula: ##STR1## wherein: R1 and R2 are, independently, selected from H;... | 06/05/2001 |
| 6225302 | Amidino protease inhibitors Amidino and benzamidino compounds, including compounds of the formula: ##STR1## wherein R1 -R4, R6 -R9, Y, Z, n and m are set forth in the specification, as well as hydrates, solvates or pharmaceutically accepta... | 05/01/2001 |
| 6165230 | 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes A 1,4-diazacycloheptane derivative and an oxidative hair colorant containing the derivative as a primary intermediate is presented. The 1,4-diazacycloheptane derivative is of the formula: ##STR1## where R1, R2, R3 and... | 12/26/2000 |
| 6103719 | Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds The invention relates to new compounds of general formula I ##STR1## or the pharmaceutically acceptable salts thereof, wherein X=N--R3 or CH--R4, Y=CH2 or (CH2)2, Z=O or H2 ; and R1 | 08/15/2000 |
| 6093733 | Muscarinic receptor agonists This invention relates to a novel class of partial or full muscarinic receptor agonists intermediates for their preparation, and pharmaceutical compositions and methods of use for the treatment or prevention of diseases the treatment or prevention of whic... | 07/25/2000 |
| 6075146 | Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals The invention relates to intermediates and processes for producing benzothiophenes employing hydroxylamines.... | 06/13/2000 |
| 6022938 | Compounds with isocyanate groups and masked groups reactive in relation to isocyanates Isocyanato compounds with capped, isocyanate-reactive groups are those of the formula I ##STR1## where R1 and R2 are hydrogen, C1 -C10 -alkyl, C6 -C10 -aryl or C7 -C10 | 02/08/2000 |
